CD14 and cancer: In the past few years, the immunosuppressive functions of CD14+HLA‐DR‐/low MDSCs were described by several researches, and the expansion and functional importance of CD14+HLA‐DR‐/low MDSCs in patients with cancer and noncancer pathogenic conditions has been recognized 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28.